Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
Both of my sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema.; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): AE-021189. An 8-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "eczema" (not ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "Both of my sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema.". Additional information: Both of the reporter's sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema. The reporter did not treat sons in the past for eczema due to side effects from available drugs for eczema. 16 years old son is at least 5 inches or more taller than most people in family or wife's family. The reporter thinks those 2 potential benefits to look into regarding Covid-19 vaccine. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : AE-021189 Biontech SE;US-PFIZER INC-PV202500122832 same reporter/suspect vaccine/event; different patient;
Medical History/Concurrent Conditions: Eczema